Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). DanCann Pharma AS's share price for the quarter that ended in Sep. 2025 was $10. DanCann Pharma AS's Shares Outstanding (EOP) for the quarter that ended in Sep. 2025 was 3.99 Mil. Therefore, DanCann Pharma AS's market cap for the quarter that ended in Sep. 2025 was $39.91 Mil.
DanCann Pharma AS's quarterly market cap
stayed the same
from Mar. 2025 ($39.91 Mil) to Jun. 2025 ($39.91 Mil) and
stayed the same
from Jun. 2025 ($39.91 Mil) to Sep. 2025 ($39.91 Mil).
DanCann Pharma AS's annual market cap
stayed the same
from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($0.00 Mil) but then
increased
from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($39.91 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. DanCann Pharma AS's Enterprise Value for Today is $0.01 Mil.
DanCann Pharma AS (GREY:DCPXF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
DanCann Pharma AS Market Cap Related Terms
DanCann Pharma AS Market Cap Historical Data
* Premium members only.
The historical data trend for DanCann Pharma AS's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, DanCann Pharma AS's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DanCann Pharma AS Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, DanCann Pharma AS's Market Cap distribution charts can be found below:
* The bar in red indicates where DanCann Pharma AS's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
DanCann Pharma AS's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DanCann Pharma AS (DCPXF) has a Market Cap of $0.09 Mil as of Jul. 09, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on DanCann Pharma AS and its competitors.
Is DanCann Pharma AS's Market Cap too high?
DanCann Pharma AS's current Market Cap is $0.09 Mil. The Drug Manufacturers industry median Market Cap is 210.75. DanCann Pharma AS's value of $0.09 Mil is 100% below this industry median. Overall, DanCann Pharma AS has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does DanCann Pharma AS's Market Cap compare to ZTS and UTHR?
DanCann Pharma AS's Market Cap of $0.09 Mil can be compared against companies in the Drug Manufacturers industry. The industry median Market Cap is 210.75. DanCann Pharma AS's value of $0.09 Mil is 100% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 210.75, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DanCann Pharma AS's current Market Cap of $0.09 Mil is 100% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on DanCann Pharma AS and its competitors. For the Drug Manufacturers industry, the median Market Cap is 210.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DanCann Pharma AS's current Market Cap is $0.09 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DanCann Pharma AS stock overvalued right now?
DanCann Pharma AS (DCPXF) has a current Market Cap of $0.09 Mil. The stock's GF Value™ is $37.14, compared to a current price of $10.00 — trading 73.1% below its estimated fair value. The current Market Cap is $0.09 Mil and 100% below the Drug Manufacturers industry median of 210.75. DanCann Pharma AS's overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For DanCann Pharma AS (DCPXF), the current Market Cap is $0.09 Mil as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DanCann Pharma AS (DCPXF) Overvalued in 2026?
Based on GuruFocus' analysis, DanCann Pharma AS stock appears to be undervalued.
The current stock price of $10.00 is trading 73.1% below its estimated GF Value™ of $37.14.
Key valuation signals for DCPXF:
Market Cap: $0.09 Mil
GF Value™: $37.14 vs. price of $10.00 (73.1% below fair value)
Industry Position: 100% below the Drug Manufacturers median
No single metric tells the full story. See the DCPXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DanCann Pharma AS is a Danish biopharmaceutical Company powered by cannabinoids. DanCann Pharma is a licensed production and distribution Company. The company is focused on discovering, developing, manufacturing, and commercializing novel cannabinoid therapeutics for a broad range of diseases.
20GF Score
Get the complete analysis for DCPXF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DCPXF has been successfully added to your 
